Cargando…

INCREASED RISK OF MECHANICAL VENTILATION AND DEATH IN PATIENTS WITH COVID-19 RECENTLY TREATED WITH RITUXIMAB

Detalles Bibliográficos
Autores principales:	MILES, B., MACKEY, J., CHACKO, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:	Chest Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212693/ http://dx.doi.org/10.1016/j.chest.2021.12.162

Ejemplares similares

PROLONGED COVID-19 IN PATIENTS TREATED WITH RITUXIMAB
por: WEBER, ANDREW, et al.
Publicado: (2021)

PATIENT ON RITUXIMAB CONTRACTING COVID-19 VIRUS AFTER VACCINATION
por: KHAN, AWAB, et al.
Publicado: (2021)

IN-HOSPITAL MORTALITY IN MECHANICALLY VENTILATED PATIENTS WITH COVID-19 WITH DIFFERENT ARDS PHENOTYPES
por: LEE, JOOSEOB, et al.
Publicado: (2021)

RELAPSE AND REMITTING COVID-19 INFECTIONS IN AN IMMUNOSUPPRESSED PATIENT ON CHRONIC RITUXIMAB INFUSIONS
por: GREWAL, SAHIB, et al.
Publicado: (2021)

SEVERE ADENOVIRUS PNEUMONIA IN RITUXIMAB INFUSIONS
por: BJORK, SARAH, et al.
Publicado: (2021)

CLINICAL ATTRIBUTES AND RISK FACTORS FOR MECHANICAL VENTILATION AMONG PATIENTS WITH COVID-19 IN A COMMUNITY HOSPITAL SETTING: A PROPENSITY-MATCHED ANALYSIS
por: SEETHARAM, KARTHIK, et al.
Publicado: (2021)

SARS-COV-2 INFECTION WITH RITUXIMAB THERAPY
por: AUGENSTEIN, CHERYL, et al.
Publicado: (2022)

PULMONARY BAROTRAUMA DURING NONINVASIVE VENTILATION IN PATIENTS WITH COVID-19
por: Pattupara, Archana, et al.
Publicado: (2020)

COST ANALYSIS FOR USE OF PROCALCITONIN AND INFLAMMATORY MARKERS IN COVID-19 VENTILATOR-ASSOCIATED PNEUMONIA
por: KIM, A., et al.
Publicado: (2022)

A COMPARISON OF THE INCIDENCE OF VENTILATOR-ASSOCIATED PNEUMONIA AMONG PATIENTS WITH COVID-19 AND INFLUENZA PNEUMONIA A AND B
por: GROSSMAN, J., et al.
Publicado: (2022)

DOES COVID-19 INCREASE YOUR RISK OF DEVELOPING HAIRY CELL LEUKEMIA?
por: MANDAL, SHOBHA, et al.
Publicado: (2022)

PNEUMOTHORAX IN PATIENTS WITH COVID-19 PNEUMONIA NOT ON POSITIVE PRESSURE VENTILATION: A SYSTEMATIC REVIEW OF CASE REPORTS AND SERIES
por: PATTUPARA, ARCHANA, et al.
Publicado: (2021)

PATIENT WITH RECENT COVID-19 INFECTION PRESENTING WITH ACUTE UPPER AIRWAY OBSTRUCTION
por: MIN, SUGI, et al.
Publicado: (2021)

UPFRONT COMMUNITY-ACQUIRED PNEUMONIA ANTIMICROBIAL THERAPY IS ASSOCIATED WITH REDUCED RATES OF VENTILATOR-ASSOCIATED PNEUMONIA IN PATIENTS WITH COVID-19
por: WAKEFIELD, CONNOR, et al.
Publicado: (2022)

IDENTIFICATION OF PHENOTYPES AMONG COVID-19 DEATH USING LATENT CLASS ANALYSIS
por: TENG, CATHERINE, et al.
Publicado: (2021)

COVID-19-ASSOCIATED MENINGOENCEPHALITIS TREATED WITH STEROIDS AND REMDESIVIR
por: AZAZ CHEEMA, MUHAMMAD, et al.
Publicado: (2021)

PROLONGED COVID-19 INFECTION IN AN IMMUNOSUPPRESSED PATIENT TREATED WITH CASIRIVIMAB/IMDEVIMAB
por: TOOR, SUBHAN A, et al.
Publicado: (2022)

OUTCOMES OF WHITE VS MINORITY PATIENTS WITH COVID-19 WITH ARDS TREATED WITH ECMO
por: REDDY, RENUKA, et al.
Publicado: (2021)

MULTIPLE ORGAN SYSTEMS INVOLVEMENT IN COVID-19 IS ASSOCIATED WITH INCREASED IN MORTALITY
por: LAM, ERIC, et al.
Publicado: (2021)

COVID-19 RESPIRATORY MECHANICS FEASIBILITY IN HOMELESS QUARANTINE
por: Landon, Chris, et al.
Publicado: (2020)

TNF/IFN-GAMMA AXIS FAVORS SENESCENCE AND SEVERE INFLAMMATION ASSOCIATED WITH CELL DEATH IN PATIENTS WITH COVID-19
por: PALACIOS, Y., et al.
Publicado: (2022)

BIO-MECHANICS OF ARDS IN COVID-19: A PROSPECTIVE OBSERVATIONAL STUDY
por: Naeem, Ehsun, et al.
Publicado: (2020)

DID WE NEED THOSE ANTIBIOTICS? OUTCOMES OF PATIENTS WITH COVID-19 TREATED FOR BACTERIAL SUPERINFECTION OF THE LUNGS
por: AMANZAI, ABASIN, et al.
Publicado: (2021)

THE ADDED CLINICAL VALUE OF TOCILIZUMAB IN TREATING ADULTS HOSPITALIZED WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: AL-MISTAREHI, ABDEL-HAMEED, et al.
Publicado: (2022)

COVID-19: ESSENTIAL WORKERS AND THE RISKS WE FACE
por: MAHMOOD, SYED, et al.
Publicado: (2021)

IMPACT OF DEMENTIA AS AN EARLY MORTALITY RISK FACTOR AMONG DECEASED PATIENTS WITH COVID-19
por: RUIZ, CARLOS A PEREZ, et al.
Publicado: (2022)

30-DAY AND 90-DAY OUTCOMES OF THE SURVIVORS OF COVID-19 PNEUMONIA TREATED EXCLUSIVELY WITH CPAP: RESULTS FROM A DISTRICT TEACHING HOSPITAL
por: OKPO, ERNEST, et al.
Publicado: (2021)

ELDERLY PERSON WITH COVID-19 AND SEVERE ARDS WITH PROLONGED ACTIVE VIRAL REPLICATION AND DOUBLE RESURGENCE OF CYTOKINE STORM TREATED WITH SOTROVIMAB AND CASIRIVIMAB/IMDEVIMAB
por: SIRITHANAKUL, KASEM
Publicado: (2022)

THE MULBSTA SCORE: PREDICTING RISK OF MORTALITY AND DISEASE SEVERITY IN PATIENTS WITH COVID-19 PNEUMONIA
por: Tusha, Jurgena, et al.
Publicado: (2020)

RISK FACTORS FOR COVID-19 CRITICAL ILLNESS AMONG TWO URBAN PUBLIC HOSPITALS
por: GRAZIANI, CASEY, et al.
Publicado: (2022)

CLINICAL CHARACTERISTICS AND RISK FACTORS OF MORTALITY FOR HOSPITALIZED PATIENTS WITH CANCER WITH COVID-19 INFECTION IN MACCA, SAUDI ARABIA
por: GHALEB, N., et al.
Publicado: (2022)

RISK FACTORS FOR IN-HOSPITAL MORTALITY AMONG ADULTS HOSPITALIZED WITH COVID-19: A CROSS-SECTIONAL STUDY FROM JORDAN
por: AL-MISTAREHI, ABDEL-HAMEED, et al.
Publicado: (2022)

COVID-19 CHRONIC IMPAIRMENT WITH PULMONARY SYMPTOMS
por: GOERTZEN, STEPHEN M, et al.
Publicado: (2022)

VACCINE-INDUCED ANTIBODY DEPENDENT ENHANCEMENT IN COVID-19
por: SRIDHAR, PRIYANKA, et al.
Publicado: (2022)

POSTERIOR PNEUMOTHORAX IN A PATIENT WITH COVID-19 ON ECMO: A CASE REPORT
por: BEATY, W., et al.
Publicado: (2022)

LONG-TERM MORTALITY IN HOSPITALIZED PATIENTS WITH COVID-19 AND PREEXISTING ASTHMA
por: ARGUETA, FRANKLIN A, et al.
Publicado: (2022)

PROTEINACEOUS COVID-19
por: Chandna, Sanya, et al.
Publicado: (2020)

ISCHEMIC PRIAPISM: A STARTLING THROMBOEMBOLIC COMPLICATION OF COVID-19
por: AL ARMASHI, A.R., et al.
Publicado: (2022)

A CASE OF COVID-19 PNEUMONIA IN A VACCINATED PATIENT WITH PSORIATIC ARTHRITIS
por: CHAO, C., et al.
Publicado: (2022)

COVID-19 IN LUNG TRANSPLANT RECIPIENTS: A SINGLE CENTER EXPERIENCE
por: SATHIYAMOORTHY, GAYATHRI, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q8t89c3cb9b70jev5m15nebh0s